Comparison of Chlorhexidine and Hypochlorous Acid Mouthwash After Impacted Third Molar Surgery
Postoperative Effects of Hypochlorous Acid Versus Chlorhexidine Mouthwash Following Impacted Third Molar Extraction: A Randomized Split-Mouth Study
1 other identifier
interventional
42
1 country
1
Brief Summary
Impacted mandibular third molar extraction is one of the most common procedures in oral and maxillofacial surgery and is frequently associated with postoperative complications such as pain, edema, and trismus, which may negatively affect patients' quality of life. Various pharmacological and topical agents have been used to reduce these postoperative complications. Chlorhexidine gluconate mouthwash is widely considered the gold standard antiseptic agent due to its broad antimicrobial activity; however, its use may be associated with adverse effects such as tooth staining and taste alteration. Hypochlorous acid is an alternative antiseptic agent with antimicrobial and anti-inflammatory properties and good tissue compatibility. The aim of this randomized clinical study was to compare the effectiveness of hypochlorous acid mouthwash and chlorhexidine gluconate mouthwash in reducing postoperative complications following impacted mandibular third molar surgery. A total of 43 healthy patients with bilateral impacted mandibular third molars were included in the study. Postoperative outcomes including pain (VAS), edema, trismus, and wound healing were evaluated at specific follow-up intervals. The results were analyzed to determine whether hypochlorous acid could be considered a potential alternative to chlorhexidine in postoperative oral care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 8, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedMarch 12, 2026
March 1, 2026
7 months
March 8, 2026
March 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Visual Analog Scale (VAS)
n the pain assessment, the patients were given a VAS form at 3, 6, 12 and 24 hours and on the 2nd, 3rd, 4th, 5th, 6th and 7th days and the pain felt by the patient was marked on this scale. This form consists of numbers between 0 and 10. 0 represents 'no pain at all' and 10 represents 'worst possible pain'.
3, 6, 12 and 24 hours and the 2nd, 3rd, 4th, 5th, 6th and 7th days
Trismus
In all patients participating in the study, the maximum interincisal distance for trismus was measured and recorded by the same physician before the operation and on the 2nd and 7th days after the operation.
preop, 2th and 7th days
Edema
For edema, some anatomical points on the face were taken as reference points and the distance between these points was measured with a tape measure and recorded. The angulus point was determined as the center point and the distances between angulus-tragus, angulus-lateral corner of the eye, angulus-nasal base, angulus-labial commissure and angulus-pogonion point were measured.
preop, 2th and 7th days
Study Arms (2)
chlorhexidine gluconate
ACTIVE COMPARATORPatients used chlorhexidine gluconate mouthwash starting 24 hours after surgery, three times daily.
Hypochlorous Acid Mouthwash
ACTIVE COMPARATORPatients used hypochlorous acid mouthwash starting 24 hours after surgery, three times daily.
Interventions
Hypochlorous acid mouthwash is an antimicrobial oral rinse with broad-spectrum activity against bacteria, viruses, and fungi. It is used as a postoperative antiseptic agent to reduce microbial load, inflammation, and the risk of infection following oral surgical procedures.
Patients used chlorhexidine gluconate mouthwash starting 24 hours after surgery, three times daily.
Eligibility Criteria
You may qualify if:
- Age between 18 and 40 years
- Presence of bilateral impacted mandibular third molars with similar surgical difficulty
- Good general health with no systemic disease
- Ability to comply with postoperative instructions and follow-up visits
You may not qualify if:
- Presence of systemic disease
- Pregnancy or breastfeeding
- Active infection at the surgical site
- History of allergy to study medications
- Use of antibiotics or anti-inflammatory drugs within two weeks before surgery
- Temporomandibular joint disorders causing limited mouth opening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yüzüncü Yıl Üniversitesi Diş Hekimliği Fakültesi
Van, 65580, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 8, 2026
First Posted
March 12, 2026
Study Start
December 1, 2021
Primary Completion
July 1, 2022
Study Completion
August 1, 2022
Last Updated
March 12, 2026
Record last verified: 2026-03